Argentina at a glance
- Population
- 45.9 million 2025
- Life expectancy at birth
- 77.5 years, 2024
- People aged 65 and over
- 12.6 % of people, 2025
- Health spending per person
- 1,457 US$ per person, 2023
- Doctors
- 5.11 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
Argentina Neurology Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$165.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $108.9 Mn | — | — |
| 2025 (base) | $119.9 Mn | +$11.0 Mn | — |
| 2026 (forecast) | $132.0 Mn | +$12.1 Mn | +10.1% |
| 2027 (forecast) | $145.3 Mn | +$13.3 Mn | +21.2% |
| 2028 (forecast) | $160.0 Mn | +$14.7 Mn | +33.5% |
| 2029 (forecast) | $176.2 Mn | +$16.2 Mn | +46.9% |
| 2030 (forecast) | $194.0 Mn | +$17.8 Mn | +61.8% |
| 2031 (forecast) | $213.5 Mn | +$19.6 Mn | +78.1% |
| 2032 (forecast) | $235.1 Mn | +$21.6 Mn | +96.1% |
| 2033 (forecast) | $258.9 Mn | +$23.7 Mn | +115.9% |
| 2034 (forecast) | $285.0 Mn | +$26.1 Mn | +137.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $119.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $285.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Medtronic, Boston Scientific Corporation, Abbott Laboratories, Stryker, Integra Life Sciences Corporation and 1 more (see all) |
| Regulator in Argentina | ANMATSource: ANMAT. Checked 19 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Neurology devices diagnose and treat diseases of the brain, spine and nerves, such as stimulators, monitors and shunts.
Key segments of the neurology devices market include product (Neurostimulators, Neurovascular Devices and Cerebrospinal Fluid Management) and application (Epilepsy, Parkinson's Disease and Chronic Pain).
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the neurology devices market.
Smart implants, less invasive techniques and growing access to surgery in emerging economies give the neurology devices market room to grow.
Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the neurology devices market.
The neurology devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices are registered with ANMAT according to their risk class.[1] Care is split between free public hospitals, social insurance funds run for workers (obras sociales) and private prepaid plans.[2]
[1] ANMAT. Checked 19 Nov 2026.
[2] Superintendence of Health Services (SSSalud). Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurology devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Argentina.
What doctors and scientists are doing in Neurology Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
Argentina
Argentina
Argentina
Argentina
Argentina
Argentina
Digital Health · Global
Pharmaceuticals · Global
Pharmaceuticals · Global
Healthcare Services · Global
Pharmaceuticals · Global
Pharmaceuticals · Global